Pentagon Seeks Vaccine Against Cold War ‘Q-Fever’

Chemical, biological, radiological and nuclear defense Marines with Headquarters Company, Combat Logistics Regiment 17, 1st Marine Logistics Group, train during a hazardous material course at Camp Pendleton, Calif., March 2013.

U.S. Marine Corps photo by Cpl. Laura Gauna/Released

AA Font size + Print

Chemical, biological, radiological and nuclear defense Marines with Headquarters Company, Combat Logistics Regiment 17, 1st Marine Logistics Group, train during a hazardous material course at Camp Pendleton, Calif., March 2013.

Suddenly, the Defense Threat Reduction Agency wants a vaccine for bacteria the Soviets weaponized decades ago. By Diane Barnes

The U.S. Defense Department is getting set to push for a new vaccine against “Q-fever” bacteria, an agent with a reputation as a potential terrorism tool acquired in part through its history as a government-made biological weapon.

The Pentagon’s Defense Threat Reduction Agency is planning an online forum on Dec. 5 to facilitate conversation with potential developers of a vaccine against Q fever, which is also known by the bacteria’s formal designation, Coxiella burnetii.

The United States investigated the agent’s warfare potential and the Soviet Union fully weaponized it decades ago, long before both countries formally denounced biological arms in the 1970s. The disease also occurs in nature and has affected hundreds of U.S. troops deployed overseas.

It can produce fever, pneumonia, and numerous other symptoms associated with a variety of pathogens.    

Certain antibiotics are considered effective against the bacteria, but no vaccine is presently sold in the United States, according to the Federation of American Scientists. An existing vaccination available abroad reportedly can cause side effects such as abscesses and swollen joints.

The United States “should definitely have a Q fever vaccine,” Amesh Adalja, a senior associate with the Center for Health Security at the University of Pittsburgh Medical Center, said in a phone interview. “This is still a disease that has some public health burden, in addition to its potential use as a bioweapon.”

The U.S.-led occupation of Iraq led to roughly 200 “acute” Q-fever cases among U.S. soldiers, the Centers for Disease Control and Prevention reported earlier this year.

Those infections appeared to result from unintentional exposure to animal carriers or bacteria swept up by helicopter rotors. Such naturally occurring cases rarely cause death, but Adalja suggested the agent could prove more dangerous if incorporated in a weapon.

Q-Fever bacteria infected but reportedly did not kill any conscientious war objectors deliberately exposed to the agent during U.S. Army experiments in the 1950s.

The United States has been eyeing a new Q-fever vaccine for several years. However, the agent’s status as a potential bioterrorism tool is fairly new, relative to how long it has been an established biological weapon. CDC officials only began tracking Q-fever infections in 1999, as the Clinton administration was increasing the nation’s focus on biological terrorism as a national-security threat.

A CDC list of potential bioterrorism agents and diseases, which includes Q fever, “is derived almost solely from the U.S. and Soviet bioweapons programs,” Adalja said. He suggested that the U.S. government is “substantially” more likely to fund development of vaccines and treatments for such agents than for pathogens never involved in government biological-weapons programs.

Agents more than dangerous than Q-fever may have emerged since the Cold-War height of the U.S. and Soviet biological-weapons programs, but the established track record of historical biological arms could make them particularly attractive to would-be bioterrorists, Adalja said.

Close [ x ] More from DefenseOne

Thank you for subscribing to newsletters from
We think these reports might interest you:

  • Federal IT Applications: Assessing Government's Core Drivers

    In order to better understand the current state of external and internal-facing agency workplace applications, Government Business Council (GBC) and Riverbed undertook an in-depth research study of federal employees. Overall, survey findings indicate that federal IT applications still face a gamut of challenges with regard to quality, reliability, and performance management.

  • PIV- I And Multifactor Authentication: The Best Defense for Federal Government Contractors

    This white paper explores NIST SP 800-171 and why compliance is critical to federal government contractors, especially those that work with the Department of Defense, as well as how leveraging PIV-I credentialing with multifactor authentication can be used as a defense against cyberattacks

  • GBC Issue Brief: Supply Chain Insecurity

    Federal organizations rely on state-of-the-art IT tools and systems to deliver services efficiently and effectively, and it takes a vast ecosystem of organizations, individuals, information, and resources to successfully deliver these products. This issue brief discusses the current threats to the vulnerable supply chain - and how agencies can prevent these threats to produce a more secure IT supply chain process.

  • Data-Centric Security vs. Database-Level Security

    Database-level encryption had its origins in the 1990s and early 2000s in response to very basic risks which largely revolved around the theft of servers, backup tapes and other physical-layer assets. As noted in Verizon’s 2014, Data Breach Investigations Report (DBIR)1, threats today are far more advanced and dangerous.

  • Information Operations: Retaking the High Ground

    Today's threats are fluent in rapidly evolving areas of the Internet, especially social media. Learn how military organizations can secure an advantage in this developing arena.


When you download a report, your information may be shared with the underwriters of that document.